• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定一种新型的失巢凋亡相关基因特征以预测肝内胆管癌的预后和肿瘤微环境。

Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in intrahepatic cholangiocarcinoma carcinoma.

作者信息

Zhou Xuan, Wei Bai, Wang Yan, Liu Mingjie, Guo Xiangru, Duan Yuting

机构信息

Department of Oncology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, 39 Yanhu Avenue, Wuchang, Wuhan, 430077, Hubei, People's Republic of China.

出版信息

Discov Oncol. 2025 Jun 10;16(1):1051. doi: 10.1007/s12672-025-02840-5.

DOI:10.1007/s12672-025-02840-5
PMID:40495091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12151966/
Abstract

BACKGROUND

Intrahepatic cholangiocarcinoma is a malignant tumor of hepatobiliary epithelial cells. In recent years, its incidence has gradually increased. It has a very high fatality rate and low survival rate, and the existing predictive factors for intrahepatic cholangiocarcinoma are unclear. The role of anoikis, a form of programmed cell death, in intrahepatic cholangiocarcinoma is not fully understood. This study focuses on identifying and analyzing anoikis-related differentially expressed genes in intrahepatic cholangiocarcinoma, aiming to enhance our understanding of potential treatment strategies and prognosis of intrahepatic cholangiocarcinoma.

METHODS

In our study, we employed a clustering algorithm to classify samples from The Cancer Genome Atlas (TCGA) based on differentially expressed overlapping anoikis-related genes. Subsequently, we utilized Weighted Gene Co-expression Network Analysis (WGCNA) to identify highly correlated genes and constructed a prognostic risk model based on univariate Cox proportional hazard regression. We validated the model's reliability using external datasets from the International Cancer Genome Consortium (ICGC) and the Gene Expression Omnibus (GEO). Finally, we used the CIBERSORT algorithm to investigate the correlation between risk scores and immune infiltration.

RESULTS

The results showed that the TCGA cohort could be divided into 2 subgroups, among which subgroup B had a lower survival probability. We identified three prognostic genes (EGF, BNIP3, TDGF1) associated with anorexia. The prognostic risk model effectively predicted overall survival and was validated in ICGC and GEO data sets. Furthermore, there were significant correlations between infiltrating immune cells and prognostic genes and risk scores.

CONCLUSION

We identified subgroups and prognostic genes associated with ICCA dysregulation, which are important for understanding the treatment and prognosis of ICCA.

摘要

背景

肝内胆管癌是一种肝胆上皮细胞恶性肿瘤。近年来,其发病率逐渐上升。它具有很高的死亡率和低生存率,且目前肝内胆管癌的预测因素尚不清楚。失巢凋亡作为一种程序性细胞死亡形式,在肝内胆管癌中的作用尚未完全明确。本研究聚焦于识别和分析肝内胆管癌中与失巢凋亡相关的差异表达基因,旨在加深我们对肝内胆管癌潜在治疗策略和预后的理解。

方法

在我们的研究中,我们采用聚类算法根据差异表达的重叠失巢凋亡相关基因对来自癌症基因组图谱(TCGA)的样本进行分类。随后,我们利用加权基因共表达网络分析(WGCNA)来识别高度相关的基因,并基于单变量Cox比例风险回归构建了一个预后风险模型。我们使用来自国际癌症基因组联盟(ICGC)和基因表达综合数据库(GEO)的外部数据集验证了该模型的可靠性。最后,我们使用CIBERSORT算法研究风险评分与免疫浸润之间的相关性。

结果

结果显示,TCGA队列可分为2个亚组,其中B亚组的生存概率较低。我们鉴定出三个与失巢凋亡相关的预后基因(表皮生长因子、BNIP3、畸胎瘤衍生生长因子1)。该预后风险模型有效地预测了总生存期,并在ICGC和GEO数据集中得到验证。此外,浸润性免疫细胞与预后基因和风险评分之间存在显著相关性。

结论

我们鉴定出了与肝内胆管癌失调相关的亚组和预后基因,这对于理解肝内胆管癌的治疗和预后具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/4d1528ae19a0/12672_2025_2840_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/e2dffc30478e/12672_2025_2840_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/63322e5499ee/12672_2025_2840_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/2fa63b4a9da6/12672_2025_2840_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/0af91521f373/12672_2025_2840_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/0659cbf79366/12672_2025_2840_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/f18a7c9c6c94/12672_2025_2840_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/b94bafca4aed/12672_2025_2840_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/67106d01967d/12672_2025_2840_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/4d1528ae19a0/12672_2025_2840_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/e2dffc30478e/12672_2025_2840_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/63322e5499ee/12672_2025_2840_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/2fa63b4a9da6/12672_2025_2840_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/0af91521f373/12672_2025_2840_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/0659cbf79366/12672_2025_2840_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/f18a7c9c6c94/12672_2025_2840_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/b94bafca4aed/12672_2025_2840_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/67106d01967d/12672_2025_2840_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add7/12151966/4d1528ae19a0/12672_2025_2840_Fig9_HTML.jpg

相似文献

1
Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in intrahepatic cholangiocarcinoma carcinoma.鉴定一种新型的失巢凋亡相关基因特征以预测肝内胆管癌的预后和肿瘤微环境。
Discov Oncol. 2025 Jun 10;16(1):1051. doi: 10.1007/s12672-025-02840-5.
2
Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma.识别肝癌中的凋亡相关亚群和预后模型。
Int J Mol Sci. 2023 Feb 2;24(3):2862. doi: 10.3390/ijms24032862.
3
A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.代谢相关的 4 个长链非编码 RNA 预后签名及其在肝内胆管癌中的相关机制。
BMC Cancer. 2021 May 25;21(1):608. doi: 10.1186/s12885-021-08322-5.
4
An anoikis-related gene signature predicts prognosis, drug sensitivity, and immune microenvironment in cholangiocarcinoma.一种与失巢凋亡相关的基因特征可预测胆管癌的预后、药物敏感性和免疫微环境。
Heliyon. 2024 Jun 3;10(11):e32337. doi: 10.1016/j.heliyon.2024.e32337. eCollection 2024 Jun 15.
5
Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients.鉴定新型失巢凋亡相关基因特征,预测乳腺癌患者的预后、免疫微环境和药物敏感性。
Cancer Control. 2024 Jan-Dec;31:10732748241288118. doi: 10.1177/10732748241288118.
6
Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma.无锚定相关长非编码 RNA 特征可预测肝细胞癌的预后,并与免疫浸润相关。
Anticancer Drugs. 2024 Jun 1;35(5):466-480. doi: 10.1097/CAD.0000000000001589. Epub 2024 Mar 11.
7
Identification of anoikis related subtypes and construction of prognostic model in hepatocellular carcinoma.识别肝细胞癌中的失巢凋亡相关亚型并构建预后模型。
Cell Mol Biol (Noisy-le-grand). 2023 Sep 30;69(9):219-228. doi: 10.14715/cmb/2023.69.9.34.
8
A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.基于失巢凋亡相关基因的新型分层框架预测骨肉瘤患者的预后。
Front Immunol. 2023 Jul 27;14:1199869. doi: 10.3389/fimmu.2023.1199869. eCollection 2023.
9
Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.鉴定和验证与透明细胞肾细胞癌预后相关的新型凋亡相关基因特征。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11661-11678. doi: 10.1007/s00432-023-05012-6. Epub 2023 Jul 5.
10
Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity.基于失巢凋亡相关基因的肝细胞癌预后模型:免疫景观分析与药物敏感性预测
Front Med (Lausanne). 2023 Jul 12;10:1232814. doi: 10.3389/fmed.2023.1232814. eCollection 2023.

本文引用的文献

1
Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis.中性粒细胞与嗜酸性粒细胞比值(NER)在癌症中的预后价值:一项系统评价和荟萃分析
Cancers (Basel). 2024 Oct 31;16(21):3689. doi: 10.3390/cancers16213689.
2
Identification and validation of an anoikis-related genes signature for prognostic implication in papillary thyroid cancer.鉴定和验证与细胞凋亡相关的基因特征,以预测甲状腺乳头状癌的预后。
Aging (Albany NY). 2024 Apr 24;16(8):7405-7425. doi: 10.18632/aging.205766.
3
The role of FGFR inhibitors in the treatment of intrahepatic cholangiocarcinoma-unveiling the future challenges in drug therapy.
FGFR抑制剂在肝内胆管癌治疗中的作用——揭示药物治疗面临的未来挑战
Hepatobiliary Surg Nutr. 2023 Oct 1;12(5):790-794. doi: 10.21037/hbsn-23-411. Epub 2023 Sep 15.
4
Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data.免疫检查点抑制剂相关听力损失:一项系统评价和个体患者数据分析。
Support Care Cancer. 2023 Oct 11;31(12):624. doi: 10.1007/s00520-023-08083-w.
5
Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma.开发一种用于肝细胞癌失巢凋亡的预后模型,并鉴定关键基因。
Sci Rep. 2023 Sep 7;13(1):14723. doi: 10.1038/s41598-023-41139-9.
6
Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and validation.尿路上皮膀胱癌中与 anoikis 相关基因和分子亚型鉴定的临床价值及验证
Front Immunol. 2023 May 18;14:1122570. doi: 10.3389/fimmu.2023.1122570. eCollection 2023.
7
Active eosinophils regulate host defence and immune responses in colitis.活性嗜酸性粒细胞可调节结肠炎中的宿主防御和免疫反应。
Nature. 2023 Mar;615(7950):151-157. doi: 10.1038/s41586-022-05628-7. Epub 2022 Dec 12.
8
Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy.膀胱癌患者 anoikis 相关长非编码 RNA 免疫浸润的综合分析与免疫治疗。
Front Immunol. 2022 Nov 25;13:1055304. doi: 10.3389/fimmu.2022.1055304. eCollection 2022.
9
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians.肝内胆管癌治疗进展:临床医生当前及未来治疗前景概述
CA Cancer J Clin. 2023 Mar;73(2):198-222. doi: 10.3322/caac.21759. Epub 2022 Oct 19.
10
Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway.肝细胞癌和肝内胆管癌的预后及治疗靶点研究进展:河马信号通路
Front Oncol. 2022 Aug 12;12:937957. doi: 10.3389/fonc.2022.937957. eCollection 2022.